Indivior (INVVY) Stock Price, News & Analysis

Company Overview

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Key Stats

• Today's Range: $21.64 to $21.85
• 50-Day Range: $21.85 to $21.85
• 52-Week Range: $14.76 to $35.50
• Volume: 8,100 shs
• Average Volume: 3,825 shs
• Market Capitalization: $3.01 billion
• P/E Ratio: 20.81
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INVVY Stock Analysis - Frequently Asked Questions

How have INVVY shares performed this year?

Indivior's stock was trading at $21.8455 at the beginning of the year. Since then, INVVY stock has increased by 0.0% and is now trading at $21.8455.
View the best growth stocks for 2025 here.

How do I buy shares of Indivior?

Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:INVVY
• Previous Symbol: NASDAQ:INVVY
• CIK: 1625297
• Web: www.indivior.com
• Phone: 804-379-1090
• Fax: 804-379-1215
• Employees: 800
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 20.81
• Forward P/E Ratio: 17.62
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $791 million
• Price / Sales: 3.81
• Cash Flow: $1.15 per share
• Price / Cash Flow: 18.94
• Book Value: $1.45 per share
• Price / Book: 15.07

Miscellaneous

• Outstanding Shares: 137,880,000
• Free Float: N/A
• Market Cap: $3.01 billion
• Optionable: Not Optionable
• Beta: 0.35